ENOB FL 11
Alternative Names: ENOB-FL-11Latest Information Update: 28 Jun 2024
Price :
$50 *
At a glance
- Originator G-Tech Bio
- Developer Renovaro Biosciences
- Class Influenza virus vaccines; RNA vaccines; Synthetic vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Influenza virus infections
Most Recent Events
- 28 Jun 2024 No recent reports of development identified for preclinical development in Influenza-virus-infections in USA (Inhalation)
- 09 Aug 2023 Enochian BioSciences is now called Renovaro Biosciences
- 21 Jun 2021 Enochain Bioscience enters into a licensing agreement with G Tech Bio, LLC and Seraph Research Institute for Influenza virus infections prevention (Enochian Bioscience pipeline June 2021)